Aclaris Therapeutics
Price & Volume
Stats
See moreOpen | $1.78 |
Previous Close | $1.75 |
Day Range | $1.75-$1.82 |
52W Range | $1.05-$5.17 |
Market Cap | $196M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $16.7M |
Revenue Growth (YoY) | -35.8% |
Gross Profit (12 Mos) | -$36.3M |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 24 days ago
What's going on in today's after hours session
Yahoo Finance • 24 days ago
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
Yahoo Finance • 26 days ago
Aclaris Therapeutics Announces Leadership Transition
Yahoo Finance • 2 months ago
Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
About
CEO | Dr. Neal S. Walker D.O., M.D. |
Address | 701 Lee Road, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
